• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭开肢端肥大症的遗传奥秘:探索遗传学在一种罕见疾病中的作用。

Unlocking the Genetic Secrets of Acromegaly: Exploring the Role of Genetics in a Rare Disorder.

作者信息

Balinisteanu Ioana, Caba Lavinia, Florea Andreea, Popescu Roxana, Florea Laura, Ungureanu Maria-Christina, Leustean Letitia, Gorduza Eusebiu Vlad, Preda Cristina

机构信息

Endocrinology Department, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.

Medical Genetics Department, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.

出版信息

Curr Issues Mol Biol. 2024 Aug 20;46(8):9093-9121. doi: 10.3390/cimb46080538.

DOI:10.3390/cimb46080538
PMID:39194755
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11352740/
Abstract

Acromegaly is a rare endocrine disorder characterized by the excessive production of growth hormone (GH) in adulthood. Currently, it is understood that certain pituitary neuroendocrine tumors (PitNETs) exhibit a hereditary predisposition. These tumors' genetic patterns fall into two categories: isolated and syndromic tumors. The isolated forms are characterized by molecular defects that predispose exclusively to PitNETs, including familial isolated pituitary adenomas (FIPAs) and sporadic genetic defects not characterized by hereditary predisposition. All the categories involve either germline or somatic mutations, or both, each associated with varying levels of penetrance and different phenotypes. This highlights the importance of genetic testing and the need for a more comprehensive view of the whole disease. Despite the availability of multiple treatment options, diagnosis often occurs after several years, and management is still difficult. Early detection and intervention are crucial for preventing complications and enhancing the quality of life for affected individuals. This review aims to elucidate the molecular, clinical, and histological characteristics of GH-secreting PitNETs, providing insights into their prevalence, treatment nuances, and the benefits of genetic testing for each type of genetic disorder associated with acromegaly.

摘要

肢端肥大症是一种罕见的内分泌疾病,其特征是成年后生长激素(GH)分泌过多。目前已知,某些垂体神经内分泌肿瘤(PitNETs)具有遗传易感性。这些肿瘤的遗传模式分为两类:散发性和综合征性肿瘤。散发性肿瘤的特征是仅易患PitNETs的分子缺陷,包括家族性孤立性垂体腺瘤(FIPAs)和无遗传易感性特征的散发性遗传缺陷。所有类型都涉及种系或体细胞突变,或两者兼有,每种突变都与不同程度的外显率和不同的表型相关。这凸显了基因检测的重要性以及对整个疾病进行更全面了解的必要性。尽管有多种治疗选择,但诊断往往在数年后才进行,治疗仍然困难。早期发现和干预对于预防并发症和提高患者生活质量至关重要。本综述旨在阐明分泌生长激素的PitNETs的分子、临床和组织学特征,深入了解其患病率、治疗细微差别以及针对与肢端肥大症相关的每种遗传疾病进行基因检测的益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c98/11352740/3ce25d9f9dca/cimb-46-00538-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c98/11352740/51a09928284d/cimb-46-00538-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c98/11352740/3ce25d9f9dca/cimb-46-00538-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c98/11352740/51a09928284d/cimb-46-00538-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c98/11352740/3ce25d9f9dca/cimb-46-00538-g002.jpg

相似文献

1
Unlocking the Genetic Secrets of Acromegaly: Exploring the Role of Genetics in a Rare Disorder.揭开肢端肥大症的遗传奥秘:探索遗传学在一种罕见疾病中的作用。
Curr Issues Mol Biol. 2024 Aug 20;46(8):9093-9121. doi: 10.3390/cimb46080538.
2
Genetics of Acromegaly and Gigantism.肢端肥大症和巨人症的遗传学
J Clin Med. 2021 Mar 29;10(7):1377. doi: 10.3390/jcm10071377.
3
Screening for genetic causes of growth hormone hypersecretion.筛查生长激素分泌过多的遗传原因。
Growth Horm IGF Res. 2016 Oct-Dec;30-31:52-57. doi: 10.1016/j.ghir.2016.10.004. Epub 2016 Oct 12.
4
Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas.《垂体腺瘤遗传病因的临床与分子研究进展》
Horm Metab Res. 2020 Aug;52(8):553-561. doi: 10.1055/a-1143-5930. Epub 2020 Apr 16.
5
Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors.肢端肥大症的临床与分子遗传学:多发性内分泌腺瘤1型、卡尼综合征、麦库恩-奥尔布赖特综合征、家族性肢端肥大症及散发性肿瘤中的基因缺陷
Rev Endocr Metab Disord. 2008 Mar;9(1):1-11. doi: 10.1007/s11154-007-9066-9.
6
Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects.导致垂体肿瘤的种系和嵌合体突变:遗传和分子方面。
J Endocrinol. 2019 Feb 1;240(2):R21-R45. doi: 10.1530/JOE-18-0446.
7
Genetics of pituitary adenomas.垂体腺瘤的遗传学。
Front Horm Res. 2013;41:111-40. doi: 10.1159/000345673. Epub 2013 Mar 19.
8
Genetic Testing in Hereditary Pituitary Tumors.遗传性垂体瘤的基因检测。
Arch Med Res. 2023 Dec;54(8):102920. doi: 10.1016/j.arcmed.2023.102920. Epub 2023 Nov 24.
9
Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.家族性孤立性垂体腺瘤(FIPA)和由于芳香烃受体相互作用蛋白(AIP)基因突变引起的垂体腺瘤易感性。
Endocr Rev. 2013 Apr;34(2):239-77. doi: 10.1210/er.2012-1013. Epub 2013 Jan 31.
10
Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.在一大群散发性垂体腺瘤患者中,生殖系GPR101基因变异的频率极低,且不存在与AIP相关的双等位基因缺陷。
Eur J Endocrinol. 2016 Apr;174(4):523-30. doi: 10.1530/EJE-15-1044. Epub 2016 Jan 20.

引用本文的文献

1
Copeptin and Mid-Regional Proadrenomedullin Are Not Useful Biomarkers of Cardiometabolic Disease in Patients with Acromegaly-A Preliminary Study.copeptin和中段前肾上腺髓质素并非肢端肥大症患者心脏代谢疾病的有用生物标志物——一项初步研究
Biomedicines. 2025 Mar 8;13(3):666. doi: 10.3390/biomedicines13030666.
2
Introduction to Special Issue: Genomic Analysis of Common Disease.特刊介绍:常见疾病的基因组分析
Curr Issues Mol Biol. 2025 Feb 10;47(2):112. doi: 10.3390/cimb47020112.

本文引用的文献

1
The Preoperative Paradoxical GH Response to Oral Glucose Load Predicts a Low Risk of Recurrence in Acromegaly.术前口服葡萄糖负荷试验中生长激素的反常反应预示肢端肥大症复发风险低。
J Clin Endocrinol Metab. 2025 Apr 22;110(5):1404-1409. doi: 10.1210/clinem/dgae410.
2
An Update on the Genetic Drivers of Corticotroph Tumorigenesis.促肾上腺皮质激素细胞肿瘤发生的遗传驱动因素最新进展
Exp Clin Endocrinol Diabetes. 2024 Dec;132(12):678-696. doi: 10.1055/a-2337-2265. Epub 2024 Jun 3.
3
Germline Variants in Sporadic Pituitary Adenomas.散发性垂体腺瘤中的种系变异
J Endocr Soc. 2024 Apr 24;8(6):bvae085. doi: 10.1210/jendso/bvae085. eCollection 2024 Apr 6.
4
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism.X 连锁肢端巨大症的遗传病理生理学和临床管理
Endocr Rev. 2024 Sep 12;45(5):737-754. doi: 10.1210/endrev/bnae014.
5
The Spectrum of GH Excess in Carney Complex and Genotype-phenotype Correlations.卡尼综合征中生长激素过量的谱系及基因型-表型相关性
J Clin Endocrinol Metab. 2025 Feb 18;110(3):e694-e702. doi: 10.1210/clinem/dgae253.
6
The Genetics of Tuberous Sclerosis Complex and Related mTORopathies: Current Understanding and Future Directions.结节性硬化症及相关 mTOR 病的遗传学:现有认识和未来方向。
Genes (Basel). 2024 Mar 4;15(3):332. doi: 10.3390/genes15030332.
7
Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism.病例报告:X 连锁肢端巨大症导致的儿童巨人症的治疗。
Front Endocrinol (Lausanne). 2024 Feb 28;15:1345363. doi: 10.3389/fendo.2024.1345363. eCollection 2024.
8
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype?肢端肥大症中的致病性 RET Val804Met 变异体:一种新的临床表型?
Int J Mol Sci. 2024 Feb 5;25(3):1895. doi: 10.3390/ijms25031895.
9
KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas.在 146 例散发的生长激素垂体腺瘤中检测 KDM1A 基因分型和表达。
Eur J Endocrinol. 2024 Feb 1;190(2):173-181. doi: 10.1093/ejendo/lvae013.
10
Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review.除 MEN1 外,何时应考虑 MEN4?法国人群 5600 例患者的回顾性研究及文献复习。
J Clin Endocrinol Metab. 2024 Jun 17;109(7):e1482-e1493. doi: 10.1210/clinem/dgae055.